Detalhe da pesquisa
1.
Preexisting and treatment-emergent autoimmune cytopenias in patients with CLL treated with targeted drugs.
Blood
; 137(25): 3507-3517, 2021 06 24.
Artigo
Inglês
| MEDLINE | ID: mdl-33651883
2.
High rate of durable responses with undetectable minimal residual disease with front-line venetoclax and rituximab in young, fit patients with chronic lymphocytic leukemia and an adverse biological profile: results of the GIMEMA phase II LLC1518 - VERITAS study.
Haematologica
; 108(8): 2091-2100, 2023 08 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36632738
3.
Lymphadenopathy as a predictor of progression during venetoclax treatment in chronic lymphocytic leukemia. A campus chronic lymphocytic leukemia study.
Hematol Oncol
; 41(5): 877-883, 2023 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-37392141
4.
Beyond ibrutinib: novel BTK inhibitors for the treatment of chronic lymphocytic leukemia.
Curr Opin Oncol
; 34(6): 757-767, 2022 11 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35993294
5.
Clinical implications of cancer gene mutations in patients with chronic lymphocytic leukemia treated with lenalidomide.
Blood
; 131(16): 1820-1832, 2018 04 19.
Artigo
Inglês
| MEDLINE | ID: mdl-29358183
6.
HIF-1α is over-expressed in leukemic cells from TP53-disrupted patients and is a promising therapeutic target in chronic lymphocytic leukemia.
Haematologica
; 105(4): 1042-1054, 2020 04.
Artigo
Inglês
| MEDLINE | ID: mdl-31289209
7.
Venetoclax infectious risk score to identify patients with chronic lymphocytic leukemia at high infectious risk during venetoclax treatment: A multicenter SEIFEM study.
Am J Hematol
; 99(5): 982-984, 2024 May.
Artigo
Inglês
| MEDLINE | ID: mdl-38343033
8.
B-cell acute lymphoblastic leukemia in patients with chronic lymphocytic leukemia treated with lenalidomide.
Blood
; 137(16): 2267-2271, 2021 04 22.
Artigo
Inglês
| MEDLINE | ID: mdl-33512465
9.
CD200 included in a 4-marker modified Matutes score provides optimal sensitivity and specificity for the diagnosis of chronic lymphocytic leukaemia.
Hematol Oncol
; 2018 Mar 30.
Artigo
Inglês
| MEDLINE | ID: mdl-29602219
10.
Continuous venetoclax in treatment-naive TP53 disrupted patients with chronic lymphocytic leukemia: A chronic lymphocytic leukemia campus study.
Am J Hematol
; 98(9): E237-E240, 2023 09.
Artigo
Inglês
| MEDLINE | ID: mdl-37382471
11.
Prognostic relevance of oxidative stress measurement in chronic lymphocytic leukaemia.
Eur J Haematol
; 99(4): 306-314, 2017 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-28646624
12.
Continuous treatment with Ibrutinib in 100 untreated patients with TP53 disrupted chronic lymphocytic leukemia: A real-life campus CLL study.
Am J Hematol
; 97(3): E95-E99, 2022 03 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34904743
13.
Prediction of outcomes in chronic lymphocytic leukemia patients treated with ibrutinib: Validation of current prognostic models and development of a simplified three-factor model.
Am J Hematol
; 97(5): E176-E180, 2022 05.
Artigo
Inglês
| MEDLINE | ID: mdl-35170793
14.
Dysfunctional Vγ9Vδ2 T cells are negative prognosticators and markers of dysregulated mevalonate pathway activity in chronic lymphocytic leukemia cells.
Blood
; 120(16): 3271-9, 2012 Oct 18.
Artigo
Inglês
| MEDLINE | ID: mdl-22932792
15.
Lenalidomide can be safely combined with chlorambucil and rituximab in older patients with chronic lymphocytic leukemia.
Haematologica
; 104(1): 9-12, 2019 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30598495
16.
A scoring system to predict the risk of atrial fibrillation in chronic lymphocytic leukemia.
Hematol Oncol
; 37(4): 508-512, 2019 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-31335982
17.
Prevention and management of infectious complications in patients with chronic lymphocytic leukemia (CLL) treated with BTK and BCL-2 inhibitors, focus on current guidelines.
Blood Rev
; 65: 101180, 2024 May.
Artigo
Inglês
| MEDLINE | ID: mdl-38331696
18.
What Does Atypical Chronic Lymphocytic Leukemia Really Mean? A Retrospective Morphological and Immunophenotypic Study.
Cancers (Basel)
; 16(2)2024 Jan 22.
Artigo
Inglês
| MEDLINE | ID: mdl-38275909
19.
CAR-modified Cellular Therapies in Chronic Lymphocytic Leukemia: Is the Uphill Road Getting Less Steep?
Hemasphere
; 7(12): e988, 2023 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-38044959
20.
Anti-tumor activity of selinexor in combination with antineoplastic agents in chronic lymphocytic leukemia.
Sci Rep
; 13(1): 16950, 2023 10 07.
Artigo
Inglês
| MEDLINE | ID: mdl-37805613